rss

Recent eLetters

Displaying 207-231 letters out of 713 published

  1. Casualty Surgeons

    Dear Sir,

    It is disappointing, in 2008, to still see our departments described as "casualty' in the journal of our new college.1 As a speciality, we have long since discarded this terminology. More recently, "Accident & Emergency" has also fallen out of use in favour of the more appropriate "Emergency Department".

    It is interesting that the case report in question is from a surgical department. While it is good to know that our surgical colleagues are now reading and submitting material to the EMJ, it would be preferable if the outdated terminology of "casualty" was filtered out at the editing stage.

    Yours Sincerely,

    Dr David Menzies

    1.N F S Watson, H Z Butt, J F Abercrombie, I Ahmed. Traumatic eversion of the umbilicus: what lies beneath? Emergency Medicine Journal 2008;25:772;

    Read all letters published for this article

    Submit response
  2. How Deep Is Your Sedation?

    Dear Editor,

    We read with interest Vardy et al's “Audit of the safety and effectiveness of ketamine for procedural sedation in the emergency department” [1]. A point of concern was that 77% of patients in their sample received propofol, midazolam or ketamine at a dose that depressed their conscious level such that they were unresponsive to verbal stimulus (scoring "P" or "U" on the AVPU scale). Furthermore, 15.9% of all patients experienced some form of complication.

    They concede a high complication rate but do not appear to consider that the level of "sedation" administered in the majority of all cases is equivalent to a general anaesthetic. The "P" of the AVPU scale is considered to correspond to a GCS of 8 [2], at which a patient is at risk of loss of airway reflexes. The recommendation put forward by the Intercollegiate Working Party on safe sedation practice considers deep sedation as a state where a patient does not respond to verbal or simple physical stimuli, with consensus that its supervision requires the same level of training and skill as general anaesthesia [3].

    We therefore have to question whether the degree of depression of consciousness achieved in this cohort might adversely affect the level of care offered. It would be interesting to ascertain the level of anaesthetic and life support training undertaken by those staff performing the sedation for these procedures, given that a proportion of the SHO workforce will constitute FY2 doctors, and around 50% of those who are ACCS ST doctors will be ST1, neither group of which can be assumed to have achieved basic anaesthetic competencies [4].

    There is a clear case for further regulating procedural sedation in the Emergency Department, rather than simply introducing new and alternative agents.

    [1] Audit of the safety and effectiveness of ketamine for procedural sedation in the emergency department. Vardy, JM. Dignon, N. Mukherjee, N. Sami, DM. Balachandran, G. Taylor, S. Emergency Medicine Journal 2008;25:579-582 [2] Simple bedside assessment of level of consciousness: comparison of two simple assessment scales with the Glasgow Coma Scale. McNarry, AF. Goldhill, DR. Anaesthesia 2004;59:34-37 [3] Implementing and ensuring safe sedation practice for healthcare procedures in adults. Report of an Intercollegiate Working Party chaired by The Royal College of Anaesthetists; The Academy of Medical Royal Colleges, London, 2001 [4] Modernising Medical Careers: educational implications for the Emergency Department. McGowan, A. Emerg Med J 2006;23:644-646.

    Competing Interests: None

    Read all letters published for this article

    Submit response
  3. Look again! Delayed traumatic rupture of the diaphragm

    Dear Sir,

    Please find enclosed our article submitted to European Journal of Anaesthesia, which was presented as a poster in Euro anaesthesia conference in Copenhagen on 31 May 2008 and also published in their May supplement, including the images.( A.Arora, K.Kada, A.Ferguson; Look again! Delayed traumatic rupture of diaphragm radiologically simulating a pneumothorax; Eur J Anaesthesiology 2008; 25 (suppl 44): 13AP1-3).

    Our case is similar to yours except for the fact that a CT scan was done based on clinical finding and X-ray before considering drainage and hence it avoided the complication described in your presentation.

    Background and Goal of Study:

    Diaphragmatic injury with herniation is a well-documented complication of both penetrating and blunt trauma. It occurs in approximately 3% of abdominal and 1.5% of thoracic injuries with a 2:1 ratio of penetrating to blunt trauma. It is left-sided in 70-80% of cases. Diagnosis requires a high index of suspicion as many cases are missed at first presentation.

    We describe a case of delayed traumatic diaphragmatic hernia radiologically simulating tension pneumothorax.

    Materials and Methods:

    6 months prior to presentation a 52 year old bricklayer had fallen from a ladder. Chest X-ray at that time demonstrated undisplaced rib fractures with no pneumothorax and follow-up was not thought necessary.

    He came to hospital on this occasion with a one month history of dull upper abdominal pain. Repeat chest X-ray showed unilateral radiolucent hemithorax on the left with a few broken ribs on that side and mediastinal shift to the right; a scaphoid abdomen was noted on examination.

    After review of the film, needle thoracocentesis was deferred and a CT scan performed. This showed a diaphragmatic hernia containing transverse colon. He underwent thoraco-abdominal repair of diaphragmatic hernia.

    Results and Discussion:

    The injury is uncommon, occurring in about 4% of victims of major closed chest or abdominal trauma.(1-4) Large pressure differentials between the chest and abdomen, generated at the time of injury, cause tearing of the dome of the diaphragm, more commonly on the left as the liver protects the right side by spreading the forces more evenly. The injury is indicative of severe trauma and injuries that accompany such trauma often take priority at presentation, resulting in injury to the diaphragm being overlooked.

    In some series this has been overlooked in up to roughly two thirds of patients. The patient may present months or years later in one of two ways. The first way is with mild symptoms typically in the lower chest, or epigastric pain occurring intermittently and often brought on by taking food; physical signs are minimal. This is the so called "latent" stage.

    The clinical picture may change dramatically and the patient present in the so called "late" stage with severe symptoms of pain, breathlessness, and intestinal obstruction or gastrointestinal haemorrhage.

    Examination may show that the patient is in shock. There may also be evidence of mediastinal shift, and bowel sounds may be audible in the chest. Nearly all such patients will have presented previously with minor "latent" symptoms.

    Treatment at any stage of the illness requires an operation. Reduction of herniated contents and closure of the defect is undertaken at the time of diagnosis through a laparotomy incision in the case of an acute onset and by an appropriate thoracotomy in chronic cases.

    Surgery performed during the "latent" stage carries a perioperative mortality of under 10%4. When surgery is undertaken in the presence of strangulation, in the "late" stage, there is a mortality of between 20% and 80%.(3)

    Conclusion:

    As most patients will present with minor symptoms before presenting with a severe illness the diagnosis must always be borne in mind. In all cases an accurate history (particularly trauma), clinical alertness, and a chest radiograph are the key to diagnosis.

    References:

    1. Alyono D, Perry JF Jr. Impact of speed limit. 1. Chest injuries, a review of 966 cases. J Thorac Cardiovasc Surg 1982; 83:519-22.

    2. McCollum C, Anyarnwy CH, Umeh BUO, Swarup AS. Management of traumatic rupture of the diaphragm. BrJ3 Surg 1987; 74:181-3.

    3. Payne JH, Yellin AE. Traumatic diaphragmatic hernia. Arch Surg 1982; 117: 18-24.

    4. De la Rocha AG, Creel RJ, Mulligan GWN, Burns CM. Diaphragmatic rupture due to blunt abdominal trauma. Surg Gynecol Obstet 1982; 154:175- 80

    Read all letters published for this article

    Submit response
  4. A Seventy-Five Year Old Mistake

    Since the early 1930's there has been a mistaken belief concerning what happens when the refrigerant gas, R-22, also known as chlorodifluoromethane, is exposed to high temperature heat sources. Admittedly, several compounds, including hydrogen fluoride (which then forms hydrofluoric acid when it comes into contact with water vapor in the air), hydrogen chloride (which then forms hydrochloric acid when it comes into contact with water vapor in the air) are formed during thermal decomposition. However, the focus of all the literature and all of the training in the HVAC industry has been on the fact that a chemical compound called phosgene (carbonyl chloride) is formed when R-22 is heated. The reason for the focus on phosgene will become more evident as you read this article, but suffice it to say that phosgene has been used as a chemical weapon – it is highly toxic.

    R-22 was one of several refrigerant gases, collectively referred to as CFC’s, that had been invented in the mid- to late 1920s to replace the highly toxic refrigerant gases then in use. Although it was widely accepted that the CFC’s were non-toxic while still performing well as refrigerants, Underwriter’s Laboratories conducted comprehensive testing of the CFC’s in the late 1920's and early 1930's. Because of the chemical makeup of CFC’s one concern of UL was what would happen if these gases were heated to high temperatures. In answering that question as to R-22, UL anticipated that phosgene might be one of the products formed. Subsequent testing by UL verified (incorrectly) this prediction.[1] Since that time, this belief that phosgene is formed when R-22 is heated has become an incontrovertible postulate in the HVAC industry.

    Phosgene was a concern for three reasons. First, as mentioned, it was used as a war gas in World War I and is extremely harmful even in very low doses. Second, very low amounts of R-22 were thought to be needed to create toxic levels of phosgene. Third, there was one critically important, but quite unique aspect of phosgene. Every other product of R- 22 thermal decomposition is highly noxious and unpleasant. When these substances come into contact with mucous membranes in the eyes, mouth, nose and throat, they produce great discomfort and pain. The detection threshold is such these compounds are detected well before they reach harmful levels and the substantial discomfort that is caused upon hitting the detection threshold causes people to flee quickly...very quickly. On the other hand, phosgene is insidious. At levels which are dangerous to humans, phosgene smells something like new mown hay...sort of sweet and musty. It is not even an unpleasant smell much less a noxious one.

    Given the evidence and universal belief that R-22 produces phosgene when it comes into contact with hot surfaces, its presence in the home is viewed as a potentially dangerous and perhaps even lethal situation. And, the fact that the damage may be done by phosgene before one even knows he’s been exposed, gives rise to all kinds of potential claims. Consequently, when a component of an HVAC unit leaks refrigerant gas into a home (or other inhabited location), lawsuits against the manufacturers of HVAC equipment claiming damage due to exposure to phosgene will result. While the great weight of historical information and documentary evidence actually supports such an argument, scientifically, we now know it is wrong.

    In 2003, the authors herein acted as co-defense counsel for two separate defendants in a case where a family of four, we’ll call them the Smith family, made a “R-22 = phosgene” contention. There was no dispute that the evaporator coil of the Smith’s A/C system leaked R-22, and it was possible if not probable that a small amount of R-22 actually got from the unit located in the garage into their home. With evidence of heat sources from gas stove burners, pilot lights, toaster elements, curling irons, etc. the family was convinced that they had been exposed to phosgene. The Smith’s claimed to have experienced a wide variety of symptoms: some consistent with phosgene exposure and others that could not have possibly resulted from phosgene exposure. They claimed that the “phosgene contamination” damaged their health, and permanently and irreparably damaged their home and their personal property that was in the home. The only solution was to destroy all of their personal property, raze the house to bare land, and rebuild everything.

    Notwithstanding a virtual mountain of evidence against them, defense counsel, using a toxicologist, a forensic organic chemist and an article which was written by a DuPont researcher who worked with Freon routinely, were able to systematically layout not only the reason phosgene could not be obtained from heating R-22 but were able to explain the UL testing errors that created the original mistaken belief as to this phosgene being produced from heating R-22. Unfortunately, the Smiths were so heavily invested in their belief and position, while they heard the same evidence the jury heard, the Smiths could not accept either the indisputable scientific evidence or the jury’s decision.

    Unfortunately, there was nothing about the Smith decision which became known outside of the actual case itself. So, when the R-22-phosgene issue arose in another case, Johnson v. American Standard, Inc., the attorneys in that matter had no knowledge as to what had happened in the Smith case. Those defense attorneys clearly did not know about organic chemistry. They had no alternative but to use HVAC technicians as expert witnesses. Since virtually the entire world of HVAC technicians all believe the R-22-phosgene connection, the only information available to defense counsel was that when you heat R-22, you produce phosgene!

    The Johnson matter wound its way through the court system for years, eventually being decided by the California Supreme Court. It was dismissed by the trial court using a somewhat new legal challenge called the “sophisticated user” doctrine. The Appellate Court upheld the trial court. Finally, the California Supreme Court was asked to review the decision of the lower court. This case was decided April 3, 2008. It began when an HVAC technician did work on a commercial A/C system which required doing some brazing work [2] on a component of the system. Using standard protocol, the technician removed the R-22 refrigerant gas from the system before he began brazing, however trace amounts remained. While brazing, he was hit with a very pungent, potent and unpleasant odor that he contended was phosgene. He alleged the highly toxic gas caused him permanent lung damage. Since California workers compensation law prevented him from suing his employer, his lawyer creatively sued the manufacturer of the A/C system (American Standard) claiming that it owed the plaintiff a duty to warn him about exposure to phosgene if he heated a part of the system that contained R-22.

    The manufacturer defended the lawsuit with the sophisticated user doctrine. The plaintiff’s expert sought to establish that the plaintiff was exposed to phosgene which caused him lung damage. The defendant’s expert not only agreed with the plaintiff’s expert but attempted to also prove that phosgene was produced by heating R-22 AND that this was common knowledge among the HVAC technicians of the world. Thus, there was no need to warn Johnson of something he (and every other HVAC person) obviously knew or should have known! The court agreed with the defendants’s position, finding that everyone in the HVAC business knows about the R-22/phosgene connection. The problem is it simply isn’t true.

    While the defendant’s position was legally sound it is scientifically wrong and dangerously so. The next time that American Standard has to deal with a phosgene case, it may not be a Johnson-type sophisticated used case, but a homeowner case. The difference will be that in the Smith case, notwithstanding the overwhelming evidence against our position, we were able to demonstrate to the jury that phosgene is not a thermal decomposition product of R-22. That will not be a viable option for American Standard (it admitted R-22 can create phosgene), or perhaps most other HVAC manufacturers. They will be stuck with American Standard’s position in the Johnson case and will not know how to challenge it. Furthermore, there is the implication that even the California Supreme Court has now validated the finding concerning the phosgene/R-22 connection.

    Consider where this leaves us. There is a 75 year old mistake that appears to have no legitimate prospect for being corrected and even worse, seems to be gaining proponents and is being re-enforced, both in the HVAC trades and in the legal arena. In an already litigious society, this simply encourages more law suits. It also victimizes innocent people. When a homeowner is concerned about what he may have been exposed to when he is told his A/C unit had to be recharged with Freon by a technician performing routine maintenance on the system, he goes to the Internet and he can find a variety of horror stories about phosgene poisoning from a leaky A/C system. For example, see the following website: http://www.toxichome.net/the_real_story.htm. The family who has this website, the Veerkamps, were charged a large amount of money by lawyers and consultants to tilt at windmills.

    Consider a nationally-known company who, on its website, makes the following statement:

    “The most dangerous and most common cause of indoor air contamination comes from leaking refrigerants contacting a heat source that can convert the freon into deadly phosgene gas (mustard gas). Carbon sooting frequently evidences the presence of this reaction. Almost all air conditioners and many refrigerators leak freon. There are many sources of heat in the home (heat strips, pilot lights, electric range and oven, toasters, etc.), which are capable of converting the freon into phosgene gas.”

    This company offers to “test” your home for these substances for fees ranging from $300 to $5,000. The entire general public who have either A/C units or refrigerators are at risk in the sense that they are told that ordinary household appliances may expose them to a horrible war gas and that they can have their homes tested for its presence by spending $5,000, when, in fact, none of the information quoted above is accurate, correct or truthful. This 75 year old mistake is causing people to spend substantial sums of money looking for the nonexistent while simultaneously creating the potential of creating the next area of mass tort litigation in the United States.

    ENDNOTES

    [1] It is not the intent of the authors to be critical of the UL investigators who made these findings. Based upon the then state of knowledge of electrochemical bonding energies and the unavailability of tools such as gas chromatographs and mass spectrometers routinely used by chemists of today, the UL investigators came to conclusions that were completely appropriate in the 1930s. It is only with the advantages of contemporary increases in knowledge and modern diagnostic devices which make our hindsight 20/20 enabling us to “see” and understand the mistake made by the original investigators.

    [2] Brazing is a process that uses a propane or butane type torch and is more or less a process that lies between soldering and welding. Most significantly, it involves creating high temperatures of the objects being brazed.

    Kent Seitzinger John Broghammer

    Read all letters published for this article

    Submit response
  5. Dying for family doctors

    Editor

    We agree with the sentiments in the unsigned piece ‘A resuscitation too far’ in this month’s EMJ supplement. These poor patients are seen many times every day throughout emergency departments in Hong Kong as well as in the United Kingdom.

    We were concerned though by the suggestion of the ‘Elderly Flying Squad’ outreach service, as we read it to imply that this could or should be undertaken by emergency physicians. We beg to differ: has this not always been the role of the family doctor?

    Nursing homes should contract with family doctors or appropriate local specialists (geriatricians, palliative care specialists) to make appropriate and humane ‘not-for resuscitation’ decisions, to spare these patients the indignity of dying in the emergency department or medical receiving ward of an acute hospital.

  6. Contact burns from hair straighteners: a new hazard in the home

    We read with interest the article by Duncan et al (1) making us aware about the increasingly common household hazard of contact burns due to hair straighteners particularly in children. We would also like to share similar experience in our department of 2 cases who presented with contact burns from hair straighteners.

    Case 1: 18 month old boy with superficial partial thickness burn over the palmar aspect of his left middle finger extending form the proximal interphalangeal crease till the pulp of the finger.

    Case 2: 24 month old boy with superficial partial thickness burns over the palmar aspect of his left little finger from proximal interphalangeal crease till middle interphalangeal crease; ring finger from proximal interphalangeal crease till middle interphalangeal crease and hypothenar eminence of the same hand measuring 1cm× 1.2cm along with 2 large blisters.

    In both the cases the mechanism was accidental contact and possibility of non-accidental injury was ruled out. Both of the cases were managed conservatively, the blisters were left intact (2) and the wounds were covered with chlorhexidine acetate 0.5% (Bactigrass®) dressing. The burns in both the cases healed spontaneously without any residual scarring.

    We completely agree with the authors that hair straighteners are becoming increasingly common potential hazard as more and more of such cases are reported. This preventable cause of childhood morbidity has not been well recognised. Since these burns are potentially avoidable the public need to be made aware by education and the manufacturing companies should compulsorily add a word of caution to “keep away from children” by legislation.

    References:

    1) Duncan RA, Waterson S, Beattie TF, Stewart K. Contact burns from hair straighteners: a new hazard in the home. Emerg. Med. J 2006;23;e21

    2) Swain, AH, Azadian, BS, Wakeley, CJ, Shakespeare, PG. Management of blisters in minor burns; British Medical Journal 1987;295(6591);181

    Read all letters published for this article

    Submit response
  7. Aconite - advice on more than a name

    McGregor et al. (1) posed the question “What is the difference…between monkshood and wolfsbane?”, but looked to a work of fiction for the answer, rather than a botanical text. Monkshood is a common name for Aconitum napellus, which is native to the UK, and has blue -mauve flowers. Wolfsbane, or wolf’s bane, refers to A. lycoctonum, a yellow-flowered species from continental Europe through to Western Asia. The images in the article were taken from TOXBASE, which has permission to use this copyright material. They originally came from the CD-ROM identification system produced jointly by Royal Botanic Gardens Kew and Guy’s Poisons Unit(2). If the CD-ROM itself had been consulted the confusion over the common names would have been avoided. Also note that although the left image is of A. napellus, the right is of A. carmichaelii ‘Kelmscott’. TOXBASE includes information for all species of Aconitum under the name of a single species, A. napellus, without any differentiation.

    In Chinese medicine the potential toxicity of species such as Aconitum carmichaelii and A. kusnezoffi is well understood so the roots are processed to hydrolyse and detoxify the aconitine alkaloids before oral therapeutic use. We have also found that cases of poisoning tend to result from incorrect preparation or use of the root(3). In contrast to Hong Kong, in the UK, medicinal use of Aconitum species is restricted by Statutory Instrument 2130(1977) so incidents of poisoning are rare. In the 15 years that we have been investigating and monitoring adverse effects from herbal medicine, we are aware of 3 cases of possible Aconitum poisoning in the UK. Health professionals who are concerned about Chinese herbs and require advice on use or safety can contact us for specialist information, by email chimas@gstt.nhs.uk or phone 0207 771 5157.

    (1) McGregor AC, MacMillian MH, Ferguson J. Potter’s Potions Emerg Med J 2008;25:217-218 (2) Dauncey E (ed.) Poisonous Plants and Fungi in Britain and Ireland. Interactive identification systems on CD-ROM. Royal Botanic Gardens, Kew and Medical Toxicology Unit, Guy’s & St Thomas’ Hospital Trust, 2000. (3) Shaw D, Leon C, Kolev S et al. Traditional Remedies and Food Supplements – a 5 year toxicological study. Drug Safety 1997;17(5):342- 356

    Read all letters published for this article

    Submit response
  8. Contact burns from hair straighteners: a new hazard in the home

    We read with interest the article by Duncan et al (1) making us aware about the increasingly common household hazard of contact burns due to hair straighteners particularly in children. We would also like to share similar experience in our department of 2 cases who presented with contact burns from hair straighteners.

    Case 1: 18 month old boy with superficial partial thickness burn over the palmar aspect of his left middle finger extending form the proximal interphalangeal crease till the pulp of the finger.

    Case 2: 24 month old boy with superficial partial thickness burns over the palmar aspect of his left little finger from proximal interphalangeal crease till middle interphalangeal crease; ring finger from proximal interphalangeal crease till middle interphalangeal crease and hypothenar eminence of the same hand measuring 1cm× 1.2cm along with 2 large blisters.

    In both the cases the mechanism was accidental contact and possibility of non-accidental injury was ruled out. Both of the cases were managed conservatively, the blisters were left intact (2) and the wounds were covered with chlorhexidine acetate 0.5% (Bactigrass?) dressing. The burns in both the cases healed spontaneously without any residual scarring.

    We completely agree with the authors that hair straighteners are becoming increasingly common potential hazard as more and more of such cases are reported. This preventable cause of childhood morbidity has not been well recognised. Since these burns are potentially avoidable the public need to be made aware by education and the manufacturing companies should compulsorily add a word of caution to ?keep away from children? by legislation.

    References:

    1) Duncan RA, Waterson S, Beattie TF, Stewart K. Contact burns from hair straighteners: a new hazard in the home. Emerg. Med. J 2006;23;e21

    2) Swain, AH, Azadian, BS, Wakeley, CJ, Shakespeare, PG. Management of blisters in minor burns; British Medical Journal 1987;295(6591);181

    Read all letters published for this article

    Submit response
  9. Res omnes venena sunt, dosis sola facit venenum

    Overwhelmed by the sheer number of patients included, one is tempted to accept the conclusions made Peacock et al. in their recent paper [1] on the perceived risks of morphine in acute decompensated heart failure (ADHF).

    However, in several ways their analysis is difficult to reconcile with published data and observations in the palliative care setting. It is surprising that in the rationale given for the administration of morphine, symptomatic improvement as perceived by the patient does not seem to be an issue of relevance. In the context of dyspnoea of cancer this is an important positive endpoint (reviewed e.g. by Ben-Aharon [2]), according to self rating by patients on a numeric or visual rating scale. Abernethy et al. demonstrated that the application of sustained-release morphine at low dosage provided significant symptomatic improvement in refractory dyspnoea in patients suffering from chronic obstructive pulmonary disease [3]. Morphine in the situation described in the study of Peacock et al. is usually being used for symptom management and not as a first-line treatment of ADHF. Concerning dyspnoea there was a significant difference at the timepoint of initial clinical presentation, suggesting a higher burden of symptoms for the morphine-group. However, due to the study design, no data on this issue were available. Therefore no conclusion can be drawn regarding this outcome parameter.

    In comparable settings there are numerous studies [e.g. 4,5] including patients with diseases other than cancer [3,6,7], which show that with cautious dosage respiratory depression is negligible or completely absent. Certainly these populations are different from patients with ADHF, but may be comparable in vulnerability.

    More disturbing is however a statement that the authors are repeating in different phrases, that intravenous morphine “may cause….ventilatory depression”. They underline this by reporting that “more adverse outcomes occurred in the morphine cohort, including higher rates of mechanical ventilation”, to conclude that there is “a marked increase in the association between mechanical ventilation and morphine use”. This line of arguments can hardly be followed, as there are no supporting data presented on the indication for morphine use (e.g. symptom control vs. induction of anaesthesia), the dose being administered or even the timing of morphine injection and onset of “adverse events”. Additionally there seems not to be a standardized documentation of so called “adverse events”. To underline their conclusion another retrospective study by Sacchetti is being cited. However, this author follows the same line of arguments, that the use of morphine resulted in higher frequency in the need of mechanical ventilation, not taking into account that morphine might have been used for induction of anaesthesia or had to be used due to the symptom intensity. The effect of morphine on dyspnoea had not been assessed in this study, too. In contrast to Peacock et al. palliative care literature provides evidence, that morphine given for pain relief does not affect prognosis [as reviewed in Sykes and Thorns 8].

    Are there possible explanations (other than differing underlying conditions) as to why these contradictions might arise? Three limitations of the present study are striking.

    First, the authors themselves raise the issue that the timing of administration was not provided, which precludes any meaningful analysis of the context of administration.

    Second, no data on morphine doses were recorded. Some recommendations in the literature concerning pulmonary edema (e.g. morphine “given in 2- to 4 mg i.v. boluses…”[9], but at what intervals and how many boluses ?) might result in a dose intensity beyond the recommendations for symptom control in opioid-naïve patients. Maybe the phrase “Res omnes venena sunt, dosis sola facit venenum” (Paracelsus: “All things are poisonous, it is the dose that makes the poison”) explains part of the problem.

    However a third observation might perturb the results even more. Table 8 shows an odds ratio for mortality of 5.77-10.7 (adjusted and unadjusted) in patients without mechanical ventilation. Assuming proper monitoring and excluding unattended deaths, this allows in my opinion some inference about the intentions of physicians. If there were a reasonable chance of survival, death would rarely occur without an attempt to use maximal ICU-therapy, including intubation and mechanical ventilation. It is reasonable to assume that these odds ratios indicate that in a considerable proportion of patients morphine was used as a symptomatic treatment or sedative, and that most often these unfortunate patients were considered poor candidates for artificial ventilation in the first place.

    One has to keep in mind that including large numbers of patients is not a means to eliminate bias from studies. Any of the explanations mentioned might in theory cause sufficient bias to eliminate any suspicion against morphine in this setting. On the other hand the principle of providing the optimal relief while doing as little harm as possible requires more reliable data for a sound ethical debate.

    References

    1. Peacock WF, Hollander JE, Diercks DB, Lopatin M, Fonarow G, Emerman CL. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emerg. Med. J. 2008; 25: 205-209.

    2. Ben Aharon I, Gafter-Gvili A, Paul M, Leibovici L, Stemmer SM. Interventions for alleviating cancer-related dyspnea: a systematic review. J. Clin. Oncol. 2008; 26: 2396-2404.

    3. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003; 327: 523-528.

    4. Clemens KE, Klaschik E. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. J. Pain Symptom. Manage. 2007; 33: 473-481.

    5. Clemens KE, Klaschik E. Effect of hydromorphone on ventilation in palliative care patients with dyspnea. Support. Care Cancer 2008; 16: 93- 99.

    6. Clemens KE, Klaschik E. Morphine in the management of dyspnoea in ALS. A pilot study. Eur. J. Neurol. 2008; 15: 445-450.

    7. Johnson MJ, McDonagh TA, Harkness A, McKay SE, Dargie HJ. Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study. Eur. J. Heart Fail. 2002; 4: 753-756.

    8. Sykes N, Thorns A. The use of opioids and sedatives at the end of life. Lancet Oncol. 2003; 4: 312-318.

    9. Harrisons Principles of internal Medicine, 17th edn. McGraw-Hill Professional, 2008.

    Read all letters published for this article

    Submit response
  10. The reduction of shoulder dislocations requires appropriate analgesia

    I read with interest Moharari et al study and their conclusion that intra-articular lidocaine produces the same pain relief as intravenous meperidine and diazepam and that is a suitable alternative to sedation-analgesia for closed reduction of anterior shoulder dislocation.

    The authors achieved a very high rate of successful reduction with the traction counter-traction technique by two specifically trained operators. There were no failures in the 48 patients who had their dislocations reduced, 24 patients received 25 mg of meperidine and 5 mg of diazepam and 24 patients received 20 ml of 1% lidocaine intra-articularly.

    The administered doses of analgesic in the study seem lower and that of sedative higher than those that most would normally use. The mean pain scores before reduction in both groups were 57.9 in the intravenous sedation-analgesia arm and 52.6 in the intra-articular lidocaine group, which is suggestive of insufficient analgesia in both groups and over sedation in the intravenous group, as 5 out of 24 patients had respiratory depression requiring bag mask ventilation.

    Many would use more than one technique and most would administer the combination of a titrated dose of an intravenous opiate with a smaller dose of a short acting benzodiazepine such as Midazolam. Propofol with remifentanil 1 and etomidate alone 2 are recent additions to the multiple drug combinations available.

    There must be very few situations in clinical practice where intra- articular lidocaine should be considered as first choice. Furthermore, the majority of those reducing dislocated shoulders do not have sufficient experience with its use, perhaps because it has failed to convince. Until more date is made available, intravenous sedation-analgesia in safe and effective doses should remain the first choice. Familiarity with a combination of techniques is an important advantage for successful reduction.

    Emergency medicine physicians should become proficient with a number of techniques and medications in order to quickly and safely reduce shoulder dislocations.3

    References

    1. Dunn M, Mitchell R, Souza CD, et al. Evaluation of propofol and remifentanil for intravenous sedation for reducing shoulder dislocations in the emergency department. Emerg Med J., 2006; 23(1): 57-58 2. Burton JH, Bock AJ, Strout TD, et al. Etomidate and midazolam for reduction of anterior shoulder dislocation: a randomized controlled trial. Ann Emerg Med., 2002; 40: 496-504 3. Cunningham N J. Techniques for reduction of anteroinferior shoulder dislocation. Emerg Med Aus., 2005; 17: 463-471

    Read all letters published for this article

    Submit response
  11. Re: Intra-articular lidocaine versus intravenous meperidine/diazepam in anterior shoulder dislocatio

    We appreciate Dr Plutarco E Chiquito for his interest and comments about our recently published study of Intra-articular lidocaine versus intravenous meperidine/diazepam in anterior shoulder dislocation [1]. This letter is in response to his comments; however, it should be noted that not many studies are performed in this field, many of them have similar methods and limitations, suggesting that further studies are needed. Chiquito has indicated that the successful reduction rate in our study is surprisingly high, referring to his study (unpublished data) that has reported a lower success rate; it should be noted that our study was performed in a hospital with a high load of trauma patients admitted in the center each day, many of which suffer from shoulder dislocations. As a result, our team has a long experience in performing such procedures. Chiquito has also suggested in his letter that we have prescribed subtherapeutic doses of intravenous drugs (25 mg mepiridine, 5 mg diazepam) in our study, mentioning the high pain scores in the group receiving this type of sedation. The reason is obvious, the study was performed in the emergency department setting, where there are not enough personnel and monitoring devices to take care of the patients in case any complication develops. Five out of 24 patients receiving intravenous sedation developed respiratory depression in our study, suggesting that we should have been prepared for managing complicated cases if we had used higher doses. In other words, looking after a complicated case in such a setting would be not only costly and time consuming but also dangerous and life threatening, which suggests the very dose as an appropriate value for our emergency setting. In addition, previous similar studies had also used similar doses compared to the amount prescribed in our study: The doses prescribed in the study performed by Matthew et al was 10 mg morphine and 2 mg midazolam [2], and in the Miller et al’s study was 100 mcg fentanyl and 2 mg midazolam [3]. However, in view of the fact that fixed doses may lead to complications in certain patients such as elderly individuals with a low cardiac and respiratory reserve, and pregnant women, particularly in a setting which lacks necessary therapeutic drug monitoring devices, prescribing such drugs using weight based doses rather than the fixed ones would be more appropriate. But none of the previous studies performed in this field nor our study has used such a system. Chiquito has also suggested that Etomidate alone is a safe and effective agent in patients looking forward for the procedure [4]. It should be noted that despite the fact that the very drug is commonly used for short- term orthopedic procedures, Etomidate does not have any analgesic properties. Chiquito has also recommended that asking the patients upon their pain during the procedure is a more accurate manner compared to the data gathered after the procedure similar to what was performed in our study. His hypothesis is completely true, however, not feasible; traction-counter traction is a uncomfortable procedure; as a result it is hard to receive an appropriate answer from the patient during the procedure. In closing, it should be noted that all the available data [2, 3, 5-10] indicate the method as an effective alternative in the emergency setting.

    References 1. Moharari RS, Khademhosseini P, Espandar R, Asl Soleymani H, Talebian MT, Khashayar P, et al. Intra-articular lidocaine versus intravenous meperidine/diazepam in anterior shoulder dislocation: a randomised clinical trial. Emergency Medicine Journal 2008; 25: 262-4.

    2. Matthews DE, Roberts T. Intraarticular lidocaine versus intravenous analgesic for reduction of acute anterior shoulder dislocations. A prospective randomized study. American Journal of Sports Medicine 1995;23:54-8.

    3. Miller SL, Cleeman E, Auerbach J, Flatow EL. Comparison of intra- articular lidocaine and intravenous sedation for reduction of shoulder dislocations: a randomized prospective study. Journal of Bone and Joint Surgery (American) 2002; 84-A: 2135-9.

    4. Burton JH, Bock AJ, Strout TD, et al. Etomidate and midazolam for reduction of anterior shoulder dislocation: a randomized controlled trial. Ann Emerg Med 2002; 40: 496-504.

    5. Kosnik J, Shamsa F, Raphael E, Huang R, Malachias Z, Georgiadis GM. Anesthetic methods for reduction of acute shoulder dislocations: a prospective randomized study comparing intraarticular lidocaine with intravenous analgesia and sedation. American Journal of Emergency Medicine 1999;17:566-70.

    6. Orlinsky M, Shon S, Chiang C, Chan L, Carter P. Comparative study of intra-articular lidocaine and intravenous meperidine/diazepam for shoulder dislocations. Journal of Emergency Medicine 2002;22:241- 5.

    7. Paudel K, Pradhan RL, Rijal KP. Reduction of acute anterior shoulder dislocations under local anaesthesia - a prospective study. Kathmandu University Medical Journal 2004;2:13-7.

    8. Pradhan RL, Lakhey S, Pandey BK, Rijal KP. Reduction of acute anterior shoulder dislocations: comparing intra- articular lignocaine with intravenous analgesia. Journal of the Nepal Medical Association 2006; 45: 223- 7.

    9. Suder PA, Mikkelsen JB, Hougaard K, Jensen PE. Reduction of traumatic secondary dislocations with lidocaine. Archives of Orthopaedic and Trauma Surgery 1995; 114: 233-6.

    10. Suder PA, Mikkelsen JB, Hougaard K, Jensen PE. Reduction of traumatic primary anterior shoulder dislocation under local analgesia. Ugeskrift-for-laeger 1995; 157: 3625-9.

    Read all letters published for this article

    Submit response
  12. A question of units and doses

    We commend Dr. Baskerville for highlighted the important issue of ionising radiation dose in the trauma patient population. The detail of his commentary, however, could lead to a great deal of confusion. It seems that the decision to use milligray in this commentary has been one of expediency and not necessarily accuracy. Dr. Baskerville talks of the average radiation exposure of his trauma patients, but then quotes a unit that represents maximal tissue absorption of the radiation that the body is exposed to. To explain, a CT head dose of 70.42 mGy may well be true for the dose absorbed by the cornea (if the eyes are within the CT beam), but will not represent the average dose absorbed by the patients entire head. That same CT head represents an ionising radiation exposure of approximately 3 milli sievert (mSv). This is the amount of radiation generated by the CT scanner. To quote an equivalence for mSv and mGy is erroneus if there are tissues present in the beam that are more sensitive to ionising radiation.

    Read all letters published for this article

    Submit response
  13. Validity of triage systems: use a correct outcome measure

    Dear editor,

    With interest we read the paper by van der Wulp et al.(1) It is important that the system is evaluated since it is consensus based and applied very commonly in emergency care.

    The study evaluated the reliability and validity of the Manchester Triage System (MTS). Validity was assessed by comparing the triage results (vignettes) of 55 nurses with the triage results of two MTS experts who applied the MTS to the same vignettes.

    This approach represents a reliability study that determined agreement of the MTS application in practice between nurses and experts. To assess validity of a triage system which can be considered as a diagnostic test, criteria for diagnostic research has to be applied. The gold standard has to be assessed independent of the triage result and has to be predictive for patient outcome such as disease severity.(2) Furthermore, a gold standard for urgency aims to discriminate between those patients whose condition will worsen if no immediate care is delivered and patients who can safely wait. Several standards are described: urgencies attributed by experts independent of the triage outcome, admission rate, resource use, or the reference standard for urgency.(3, 4)

    The conclusion of this study should be that the participating nurses correctly applied the MTS in 67% compared to experts.(1) Sensitivity and specificity can be used to quantify the performance of a triage system, if it is evaluated as a diagnostic test. When reliability is studied, a kappa is more appropriate. Therefore, it cannot be concluded that sensitivity of the MTS is higher in children and the results cannot be compared to the results described in the paper by Roukema et al.(3)

    We realize that it is difficult to validate triage systems due to a lack of agreement on how to judge the appropriateness of a visit to the emergency department.

    References

    1.Van der Wulp I, van Baar ME, Schrijvers AJ. Reliability and validity of the Manchester Triage System in a general emergency department patient population in the Netherlands: results of a simulation study. Emerg Med J 2008;25(7):431-4.

    2.Hardern RD. Critical appraisal of papers describing triage systems. Acad Emerg Med 1999;6(11):1166-71.

    3.Roukema J, Steyerberg EW, van Meurs A, Ruige M, van der Lei J, Moll HA. Validity of the Manchester Triage System in paediatric emergency care. Emerg Med J 2006;23(12):906-10.

    4.Van Veen M, Steyerberg E, Ruige M, Van Meurs A, Roukema J, Van der Lei J, et al. The Manchester Triage System in paediatric emergency care: validity and pitfalls. BMJ, in press 2008.

    Read all letters published for this article

    Submit response
  14. Taking the 'ouch' out of TMJ reductions!

    Dear Editor,

    We were interested to read Dr Oliphant et al’s paper on relocating temporomandibular joint dislocations (1). In our practice we prefer the Hippocratic method of reduction, but agree that this can be very worrying to the clinician as their thumbs are placed directly in line of the bite!

    To solve this problem we apply mallet splints to the examiners thumbs. This acts as thumb protection, as illustrated in figure 1. Should the patient bite down following reduction of the dislocation, there is now a safeguard.

    An additional tip is to place tape around the mallet splint, improving purchase on the teeth and preventing displacement of the splint into the oropharynx!

    We hope this modification will reduce the anxiety associated with the Hippocratic technique, and perhaps save a few emergency physicians thumbs in the process!

    Yours

    Gemma Mullen ST1 ACCS (EM)

    Simon Carley Consultant in Emergency Medicine

    References:

    1. R Oliphant, B Key, C Dawson, and D Chung. Bilateral temporomandibular joint dislocation following pulmonary function testing: a case report and review of closed reduction techniques. Emerg. Med. J Jul 2008; 25: 435 - 436.

    Read all letters published for this article

    Submit response
  15. Is metformin the real culprit?

    Thank you for the interesting case of metformin-associated lactic acidosis. It is a very rare complication of the most widely used drug treatment for Type 2 diabetes. In this case, we do not have the data regarding the patient’s previous renal function or current creatinine levels. It however seems that the patient was severely hypotensive with sepsis possibly from the chest. The critical question regarding lactic acidosis here is what proportion was contributed by metformin and what proportion from the co-existing acute critical illnesses. Lactic acidosis is a common feature in critically ill patients with multiple pathologies. Metformin-associated lactic acidosis is not necessarily due to metformin accumulation; true type B (aerobic) lactic acidosis, i.e., without an apparent associated hypoxic factor, seems exceptional (1). often the co-existing conditions cause lactic acidosis rather than metformin itself. The metformin is an incidental factor in many cases. We know that metformin inhibits hepatic gluconeogenesis without altering lactate turnover or lactate oxidation, unlike Phenformin. The lactic acidosis has been reported in type 2 diabetes patients not treated with metformin, in conditions where there is tissue hypoxia or hypoperfusion (2). In 2003, A Cochrane systematic review and meta-analysis of pooled data from 194 studies (36893 patient- years in the metformin group) showed no excess risk of fatal or non-fatal cases of lactic acidosis due to metformin when compared to other anti-hyperglycemic therapy (3) In the recently published Fremantle Diabetes study, Metformin did not increase the risk of lactic acidosis, even when risk factors were present (4). It is well known that metformin is widely prescribed even in patients with known contra-indications. Even in this group, metformin associated lactic acidosis is rare. So in summary, cases of metformin-associated lactic acidosis have been reported widely. However most of them have associated severe critical- illnesses, which may be the major contributing factor causing hyperlactataemia. Nevertheless metformin should be stopped in all cases of lactic acidosis.

    References.:-

    1.Lalau JD, Lacroix C, Compagnon P, de Cagny B, Rigaud JP, Bleichner G, et al. Role of Metformin Accumulation in metformin-associated lactic acidosis. Diabetes Care 1995; 18:779-84

    2. Aguilar C, Reza A, Garcia JE, Rull JA. Biguanide related lactic acidosis: incidence and risk factors. Arch Med Res. 1992; 23:19-24

    3. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Arch Intern Med 2003; 163:2594-602.

    4.Kamber N, Davis WA, Bruce DG, Davis TM. Metformin and lactic acidosis in an Australian community setting: the Fremantle Diabetes Study. Med J Aust. 2008 Apr 21; 188(8):446-9

    Read all letters published for this article

    Submit response
  16. Pneumperitoneum due to chest compressions?

    Sir,

    Sajith et al. 1 report a case of oesophagogastric injury and massive pneumoperitoneum after out of hospital intubation by paramedics. The patient had received 25 minutes cardiopulmonary resuscitation with chest compression by the LUCAS device prior to restoration of cardiac output.

    We report 2 similar cases after use of the LUCAS device in elderly patients.

    Case 1

    A 64 year old woman had a cardiac arrest at home. The patient received 30 minutes out of hospital CPR with the LUCAS device by the paramedics. No attempt at intubation was made and the patient was ventilated via bag-valve mask on the way to hospital. On arrival in the ED it was noted that her abdomen was grossly distended. A Size 7.5 ETT was passed first time, copious vomit was noted in the upper airways. Ventilation was difficult due to the distended abdomen, even after placement of an NG-tube. Return of cardiac output occurred 55 minutes after the initial arrest. Unfortunately, she deteriorated again soon afterwards. After discussion with her relatives a joint decision was made to withdraw further resuscitation attempts. Further history from the family revealed that the patient had suffered from COAD. After withdrawal of care surgical emphysema was noted on the anterior chest wall as well as post-mortem abdominal distension. After discussion with all staff involved in pre-hospital and ED resuscitation we decided that the suction bell of the LUCAS device had been placed correctly onto the chest wall. The coroner’s post-mortem showed no viscus perforation, but copious gastric contents in both lungs. A post-mortem diagnosis of (Ia) coronary heart disease and (II) COPD was made.

    Case 2

    A 74 year old lady was found lifeless at home. 30 minute bystander CPR and CPR by paramedics with LUCAS device was carried out prior to arrival in the ED. On arrival the thin, frail patient was noted to have a grossly distended abdomen. An NG-tube was passed and an ET-tube inserted at first attempt without any problems. Spontaneous circulation did not recur, and all efforts to resuscitate were abandoned 60 minutes after first bystander CPR. On discontinuation of the LUCAS device, it was noted that the suction bell had been incorrectly applied (too low and not in contact with the chest during the whole cycle of CPR). Also, surgical emphysema and rib crepitus was noted over the anterior chest wall. A coroner’s post mortem showed a de Bakey type I / Stanford type A dissection of the thoraco-abdominal aorta as the main cause of death. In addition, a moderate pneumoperitoneum was found with no evidence of hollow viscus perforation. Moderate emphysema was present in the lungs with no evidence of pneumothorax and no mediastinal surgical emphysema.

    Discussion

    Unfortunately, in Sajith et al1 the circumstances of the initial oesophageal intubation are not described in detail. Both our cases bear striking similarities to the case reported by Sajith et al1. Both patients exhibited a grossly distended abdomen, but without any evidence of oesophageal intubation. Both patients had surgical emphysema in the chest wall. NG-tubes were placed in both patients without any obvious reduction in distension. No viscus perforation was demonstrated on either post-mortem. Both patients were elderly and likely to have suffered from COAD. There was no demonstrable pneumothorax in either patient on post mortem examination. Oesophageal, gastric or even laryngeal ruptures after oesophageal insertion of medical devices (ET-tube, ECHO-probe, Combitube, NG-tube) are recognized, but rare events 2-7. This is usually caused by physical injury from repeated blind insertion or difficult intubation attempts, rather than the inflation pressure or the cuff of the device. The maximal inflation pressure of an AMBU-bag® via an ET-tube is 45 cm H2O 8. The power exerted by a LUCAS device onto the chest is 530-600 N/m2 9 , a force likely to be a multiple of that exerted by a hand-operated bag- valve-mask. The force of chest compressions and their relation to chest injuries has been previously described 10, 11 . It seems likely that the pneumoperitoneum was a consequence of the compressions, especially given the extent of the internal injuries 1. Likewise, the raised Troponin can be explained by the chest compressions, rather than the initial oesophageal intubation by the paramedic crew. One possible cause is distension of the stomach during bag-valve-mask ventilation, but that does not explain the pneumoperitoneum and the fact that nasogastric tube placement had little or no effect on the amount of distension. Gastric overdistension alone as a cause for the trauma seems unlikely, given the force of the bag-valve-mask contrasted with the force of the ongoing LUCAS compressions at 100 per minute. A possible explanation for the intraabdominal air is rupture of a pulmonary bulla and subsequent tracking of air through the diaphragm, a process known as pneumatosis abdominis. The location of the oesophageal trauma in 1 appears consistent with intubation trauma, but does not explain the pneumoperitoneum much further distal to that site. Since there is no post-mortem report, we do not know if perforation had actually taken place in the patient reported by Sajith et al 1. Previous studies have shown that intubation by paramedics is both safe and effective, with unrecognized oesophageal intubation being a rare event 12-15. Given the unclear evidence of the LUCAS device for overall outcome and survival, these cases should further guard from its use, especially in the elderly. Heartlands Hospital ED has suspended the use of LUCAS pending an investigation by the Medicines and Healthcare products Regulatory Agency (MHRA) and further research into the effectiveness of the LUCAS device.

    1 Sajith A, O’Donohue B et al.: CT scan findings in oesophagogastric perforation after out of hospital cardiopulmonary resuscitation. Emerg Med J 2008;25:115-6.

    2 Keldahl M, Sen S, Gamelli-Richard L: Gastric rupture after cardiopulmonary resuscitation in a burn patient. J Burn Care Res 2006;27(5):757-9.

    3 Koscielny S, Gottschall R: Die Perforation des Hypopharynx als seltene, lebensbedrohliche Komplikation der endotrachealen intubation. Der Anästhesist 2006;55(1), 45-52.

    4 Offerman SR, Holmes JF, Wisner DH: Gastric rupture and massive pneumoperitoneum after bystander cardiopulmonary resuscitation. J Emerg Med 2001; 21(2): 137-9.

    5 Richards CF: Piriform sinus perforation during esophageal-tracheal Combitube placement. J Emerg Med 1998;16(1): 37-9.

    6 Ahmed A, Aggarwal M et al.: Esophageal perforation: a complication of nasogastric tube placement. Am J Emerg Med 1998;16(1): 64-6.

    7 Miller JS, Itani KM et al.: Gastric rupture with tension pneumoperitoneum: a complication of a difficult endotracheal intubation. Ann Emerg Med 1997; 30(3): 343-6.

    8 Mackway-Jones K., Molyneux E. et al.: Advanced Paediatric Life Support, 4th edition, BMJ books, 2005. Blackwell Publishing Group.

    9 Personal communication, Medtronic Ltd, Watford (UK Distributors for Jolife AB, manufacturers of LUCAS, Lund, Sweden).

    10 Tomlinson, AE et al.: Compression force - depth relationship during out of hospital cardiopulmonary resuscitation. Resuscitation 2006;72: 364-70.

    11 Hoke RS, Chamberlain D: Skeletal chest injuries secondary to cardiopulmonary resuscitation. Resuscitation 2004 ;63: 327-38.

    12 Davis DP, Fisher R et al.: Predictors of intubation success and therapeutic value of paramedic airway management in a large, urban EMS system. Prehosp Emerg Care 2006;10(3): 356-62.

    13 Wang HE, Yealy DM: How many attempts are required to accomplish out-of-hospital endotracheal intubation? Acad Emerg Med 2006;13(4): 372-7.

    14 Pratt JC, Hirschberg AJ: Endotracheal tube placement by EMT-Basics in a rural EMS system. Prehosp Emerg Care 2005;9(2): 172-5.

    15 Rocca B, Crosby E et al.: An assessment of paramedic performance during invasive airway management. Prehosp Emerg Care 2000;4(2), 164-7

    Read all letters published for this article

    Submit response
  17. Age old debate, but some things never mentioned?

    I have read with interest over a number of years the various stances on Emergency Physicians undertaking Emergency Department RSI. There are several things that seem to be omitted from many articles repeatedly, not only isolated to those mentioned in the previously published eLetter. For instance: once the patient is intubated, who will continue their care? At what point will their care be handed over? What will be the disposition of the patient? Is it always appropriate to intubate every patient who on initial presentation appears to need intubation? Will intubation be in the patient's best interests (in the wide sense of the Mental Capacity Act 2005)?

    Not every patient with GCS 8 requires intubation (eg stroke patients, alcohol intoxication). It is not always appropriate to intubate every patient in respiratory distress, as their current illness may be the result of longstanding chronic airways disease, and there may have been discussion previously about intubation and ventilation.

    In my own experience over a number of years (and in that of others far more experienced than myself), these factors may not be taken into consideration, and precipitate intervention may occur (or be insisted upon). This is true of junior anaesthetists and emergency physicians alike. Often it is not in fact intubation that is required, but oxygenation, which may be provided by other means. Non-invasive ventilation is also now widely available, but its indications and use do not seem to be widely appreciated (by anaesthetists, medical physicians and emergency physicians all), and therefore may not be considered as an option.

    Whilst the stance that only anaesthetists should be intubating is perceived to be widespread (anecdotally), I feel that any discussion and training of emergency physicians in rapid sequence induction (and intubation) (RSI) should include training in recognition of patients in whom it may not be appropriate to perform the intervention. Also it should be a part only of training in airway and respiratory management as a whole, not in isolation.

    Our aim should always be to provide excellent patient care, and this should involve all parties to the management of a patient, from pre- hospital to intensive care through to discharge. Therefore RSI (induction AND intubation) should not be seen as a skill to be used in isolation, rather as a transition from one area of care to another when appropriate.

    Read all letters published for this article

    Submit response
  18. Surveillance of Poisons Centre Enquiries

    Dear Editor, We agree that audit of poisons centre enquiry records is important to update TOXBASE (1), however cases summaries requested from service users are more valuable. Callers often contact a poisons information service before it is possible to determine whether a patient has actually been exposed or absorbed a toxic dose, and before the full clinical effects and outcome are known. Case follow-up is therefore important for diagnostic confirmation and knowledge consolidation (2). It has been undertaken since the National Poisons Information Service (NPIS) began (3) and is the origin of a significant amount of information on TOXBASE. Although NPIS follow-up activity has recently expanded to include selected TOXBASE enquiries (4), NPIS needs to ensure that sufficient resources are allocated to improve collection and evaluation of case follow-ups.

    We support the recommendation for greater interaction between NPIS and its users to improve service quality (1) but believe that the NPIS strategy to reduce access by telephone and promote TOXBASE as an alternative (4) will reduce interaction. Although there are benefits to making poisons databases accessible to healthcare professionals, nevertheless there is a risk of not only undermining poisons centres’ efforts to gather epidemiological data, but also of reducing interaction with poisons centre staff (5). Such interaction provides enquirers with advice and estimates of risk that take account of the nature of exposure and clinical information. Experienced poisons specialists can advise on treatment when the name of a chemical product or plant is unknown, or help to identify it. Telephone conversations are a valuable opportunity for poisons specialists to clarify information when they recognise the potential for error or misunderstanding, and provide information appropriate to enquirers’ differing knowledge and experience. Moreover, the expertise and judgement of poisons specialists are widely recognized as essential for development of toxicological surveillance systems (2).

    REFERENCES

    1 Thanacoody HKR, Good AM, Waring WS, Bateman DN. Survey of cases of paracetamol overdose in the UK referred to National Poisons Information Service (NPIS) consultants. Emerg Med J 2008; 25:140-143.

    2. Waring WS, Palmer SR, Bateman DN. Alerting and Surveillance Using Poisons Information Systems (ASPIS): Outcomes from an international working group. Clin Toxicol 2007; 45: 543-548.

    3. Braimbridge MV. Poisons Information Service. Lancet 1965 Mar 13; 1(7385): 592.

    4. 6. National Poisons Information Service. National Poisons Information Service Annual Report 2006/7. Health Protection Agency, 2007 http://www.camr.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1196942160030

    5 Hoffman RS. Poison information centers and epidemiology. In Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA, Hoffman RS, Nelson LS (eds). Goldfrank’s Toxicologic Emergencies. 7th Edition, New York, McGraw Hill, 2002, 1747-1752.

    Read all letters published for this article

    Submit response
  19. better recognition of hypertension is warranted even in subjects aged

    The statement that "frequency of hypertension is very low below [the age of 35]"(1) should be qualified by the caveat that hypertension is acknowledged to be underdiagnosed in children and adolscents(2), and that, over the past decade, blood pressure has, in fact, increased in those two age groups(3). Accordingly,if anything, we are in the middle of a demographic change in the prevalence of hypertension, with the potential prospect of earlier onset of end points such as stroke, coronary heart disease, and death,traditionally employed in trials of antihypertensive therapy in the over 50's. In anticipation of these demographic changes I would suggest that we follow the advice given by Bryan Williams that the end point of treatment should shift from prevention of clinical events such as those I have enumarated, to regression of earlier structural damage so as to prevent further evolution of vascular damage in younger patients(4). Such an aim would, of necessity, entail earlier recognition of hypertension and its precurseor, pre-hypertension, even in the under 35's. Preliminary studies have already established that, in subjects of mean age 57, who are either preypertensive or have hypertension controlled to levels below 140/90 mm Hg, early markers of cardiovascular damage can regress in response to angiotensin receptor blockade(5). This partially answers the key question raised by Bryan Williams regarding the potential benefits of such treatment in younger patients(4). In spite of the documentation of regression of markers of cardiovascular damage in prehypertensive subjects(5) the issue of long-term medication in this subgroup has, however, not been finally resolved. Nevertheless, once established, the diagnosis of prehypertension confers the opportunity to offer lifestyle advice including weight reduction, moderation in alcohol intake, low-salt diet, and regular exercise so as to retard the progression from prehypertension to fully fledged hypertension. For all these reasons recognition of hypertension, and its precursor, prehypertension, in adults aged < 35 remains a worthwhile aim. References (1) Collins K., Gough S., Clancy M Screening for hypertension in the emergency department Emergency Medicine Journal 2008:25:196-9 (2) Hansen ML., Gunn PW., Kaelber DC Underdiagnosis of hypertension in children and adolescents Journal of the American Medical Association 2007:298:874-9 (3) Muntner P., He J., Cutler JA., Wildman RP., Whelton PK Trends in blood pressure among children and adolescents Journal of the American Medical Association 2004:291:2107-13 (4) Williams B Hypertension in the young Preventing the evolution of disease versus prevention of clinical events Journal of the American College of Cardiology 2007:50:840-2 (5) Duprez DA., Florea ND., Jones K., Cohn JN Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities Journal of the American College of Cardiology 2007:50:835-9

    Read all letters published for this article

    Submit response
  20. Re: Polyvenin for snake bites

    Author’s reply:

    The use of species-specific snake antivenom is more scientific, as suggested by Prof. Balasundaram, whenever correct species identification of the offender snake is possible. But species identification may not be possible in many cases of snakebites as observed in our study (65.5%). Species-specific antivenom is not freely available in India and the majority of centers use polyvalent antivenom for treating snakebite envenoming. Even in Malaysia, polyvalent antivenom is still in use, though specific antivenom is more commonly used.[1] The incidence of allergic reactions may be less common with specific antivenom, but the reactions are not unusual and even the rate of their occurrence may be species- specific.[2]

    Species identification based only on symptoms and signs of envenoming and the known prevalence of type of snakes in the locality, without observing the offender snake may not be always correct because of the similarity of some of the symptoms of envenoming by different species. Use of polyvalent antivenom may be justified in such situations and also when species-specific antivenom is unavailable.

    References:

    [1] Jamaiah I, Rohela M, Ng TK, et al. Retrospective prevalence of snakebites from Hospital Kuala Lumpur (HKL) (1999-2003). Southeast Asian J Trop Med Public Health. 2006; 37: 200-5.

    [2] Isbister GK, Brown SG, Macdonald E, White J, Currie BJ; The Australian Snakebite Project Investigators. Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Med J Aust. 2008;188: 473-476.

    Read all letters published for this article

    Submit response
  21. Re: Snakebite envenoming in Kerala

    Author’s reply:

    The opinion by Dr. S K Munshi and Dr. M Chauhan is very relevant, considering the low prevalence rate of snakebite envenoming in most of the developed countries including the UK. The London School of Hygiene & Tropical Medicine offers masters degree (MSc) in Tropical Medicine & International Health, but the training does not include learning about this important biohazard that is common in the tropical countries.[1]

    References:

    [1] http://www.lshtm.ac.uk/prospectus/masters/mstmih.html

    Read all letters published for this article

    Submit response
  22. Re: Ventricular tachycardia following snake bite envenoming

    Author’s reply:

    The concept of door to needle time/ medical contact to needle time in the treatment snakebite envenoming proposed by Prof. J Francis is important. All the patients who reached the emergency department of our institution directly, with clinical and laboratory evidence of envenoming at the time of arrival, received antivenom as soon as the diagnosis of envenoming was made. Hence the medical contact to needle time could have been small and negligible. We could not estimate the medical contact to needle time in those cases referred to us from other institutions after receiving antivenom. The higher medical contact to needle time could be an important reason for the high snakebite-related complications and mortality rates in many states of India. Lack of adequate training in the management of envenoming and fears about complications related to envenoming and the high rates of allergic reactions to antivenom, prevent primary-care physicians to start antivenom even if it is available locally. [1] Attempts to lower the medical contact to needle time by proper training of the primary-care physicians and making antivenom available even in the rural settings should reduce the snakebite-related mortality rates and complications in India.

    Though cardiac manifestations are not uncommon, ventricular tachycardia is rarely reported as a complication of snakebite envenoming as commented by Prof. Francis. The patient who developed ventricular tachycardia in our series had been a 32-year old male with viper envenoming. His ECG and echocardiography had been normal after the cure of envenoming. Electrophysiological studies had not been advised because of the absence of structural heart disease at baseline and the patient had been advised to follow up the cardiology clinic if he develops any cardiac symptoms later. The exact cause of ventricular tachycardia could not be found in this patient and we presume that his cardiac arrythmia had been a manifestation of envenoming. Even myocardial infarction in the absence of coronary artery disease had been reported as a complication of snakebite envenoming. [2]

    Cardiac manifestations may be related to various properties of snake venom that cause damage to remote tissues and organs. Cobra cardiotoxins, a family of basic polypeptides having lipid- and heparin-binding capacities similar to the cell-penetrating peptides, had been shown to induce severe tissue necrosis and systolic heart arrest in snakebite victims. [3] Tumor necrosis factor alpha and xanthine oxidase had been proposed as potential mediators of tissue injury including cardiac damage caused by viper venom. [4] L-amino acid oxidases of snake venom had been shown to cause severe pneumorrhagia, pulmonary interstitial edema, fusion of pulmonary alveoli, cardiac interstitial edema and bleeding when injected intravenously in experimental animals. [5]

    References:

    [1] Simpson ID. Snakebite management in India, the first few hours: a guide for primary care physicians. J Indian Med Assoc. 2007; 105: 324, 326, 328.

    [2] Saadeh AM. Case report: Acute myocardial infarction complicating a viper bite. Am J Trop Med Hyg. 2001; 64: 280-2.

    [3] Wang CH, Liu JH, Lee SC, Hsiao CD, Wu WG. Glycosphingolipid- facilitated membrane insertion and internalization of cobra cardiotoxin. The sulfatide.cardiotoxin complex structure in a membrane-like environment suggests a lipid-dependent cell-penetrating mechanism for membrane binding polypeptides. J Biol Chem. 2006; 281: 656-67.

    [4] Szold O, Weinbroum AA, Ben-Abraham R, Englender TE, Ovadia D, Sorkine P. Xanthine oxidase and tumor necrosis factor alpha: possible mediators of remote tissue injury after viper envenomation. Isr Med Assoc J. 2000; 2: 816-20.

    [5] Wei XL, Wei JF, Li T, et al. Purification, characterization and potent lung lesion activity of an L-amino acid oxidase from Agkistrodon blomhoffii ussurensis snake venom. Toxicon. 2007; 50: 1126-39.

    Read all letters published for this article

    Submit response
  23. Opiates should be avoided in acute decompensated heart failure

    Editor,

    We were pleased to read Peacock et al’s paper warning of the dangers of morphine therapy in acute decompensated heart failure. [1] This retrospective review was the largest yet performed, with nearly 150000 patients in the database. The most concerning finding was an increased risk of mortality with an odds ratio of 5, despite extensive risk adjustment. Their conclusion that a prospective trial is needed is correct, but does not go nearly far enough. The implication is that current practice is acceptable until proven otherwise.

    Handbooks for doctors [2] and prehospital staff [3] still advocate use of morphine (or diamorphine) in acute cardiogenic pulmonary oedema. The most recent edition of a popular emergency medicine handbook states that opioids should only be given to those with chest pain or in distress [4], and it is encouraging that in Peacock’s paper only 14% of patients received morphine. A retrospective study showing an association between morphine use and mortality is not proof of causation, but there is minimal evidence of any benefit from using morphine. A review from 2004 [5] found no evidence supporting the use of morphine, and two smaller retrospective studies suggesting an association with harm.

    In view of the extremely serious consequences of using morphine suggested by the best evidence available, the routine use of morphine in acute cardiogenic pulmonary oedema should be discontinued immediately. We should not wait until a randomised trial demonstrates harm before we stop: the onus should be on a prospective study to prove benefit.

    [1] Peacock WF, Hollander JE, Diercks DB et al. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emerg Med J 2008;25:205-9.

    [2] Longmore M, Wilkinson IB, Turmezei T, Cheung CK. Oxford Handbook of Clinical Medicine. 7th ed. Oxford: OUP; 2007. p. 787.

    [3] Greaves I, Porter K. Oxford Handbook of Pre-Hospital Care. Oxford: OUP; 2007.

    [4] Wyatt JP, Illingworth RN, Graham CA et al. Oxford Handbook of Emergency Medicine. 3rd ed. Oxford: OUP; 2006.

    [5] Graham CA. Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department. Emerg Med Austral 2004; 16:47-50.

    Competing interests: Colin Graham is a co-author for the Oxford Handbook of Emergency Medicine (reference 4 above).

    Read all letters published for this article

    Submit response
  24. Potter's potions: Aconite poisoning

    Dear Sir

    Guy’s and St Thomas’ Poisons Unit (GTPU) has over 100 enquiries about aconite poisoning on its case database. There is a large amount of literature on the subject including toxicity from the plant itself and herbal preparations; however it is a relatively rare cause of poisoning in the UK. GTPU was consulted over a fatal case of intentional aconite poisoning in 1992. This patient had a cardiac arrest soon after arrival at A&E and could not be resuscitated. Like the patient in the report by McGregor et al., he also appeared to have an interest in horticulture. Aconite poisoning (presumably because of its toxicity and speed of action) was also suggested as one of the possible causes of the death of the Pakistan cricket coach, Bob Woolmer, in 2007(1).

    In view of the number of published case reports it is disappointing that the National Poisons Information Service (NPIS) was reported as having little information on the subject. GTPU, in collaboration with The Royal Botanic Gardens Kew, produced a CD-ROM of the poisonous plants in Britain and Ireland including a monograph on aconite (2). There are no definitive treatment recommendations for aconite poisoning and management is supportive with attention to the treatment of arrhythmias. Several antiarrhythmic drugs have been used with varying success. Mexiletine has been used in a previous case (3), and was successful in an animal study at preventing aconite-induced dysrrhythmias 4).

    Following the recent decision by the Health Protection Agency (HPA) not to reinstate a contract with Guy’s & St Thomas’ NHS Foundation Trust, GTPU will no longer be able to provide a 24 hour telephone service for human poisoning. The HPA’s decision will mean the loss of expertise, commitment and innovation from GTPU as well as the potential loss of collaboration between the NPIS and The Royal Botanic Gardens, Kew. The future long-term provision of poisons information in the UK, particularly in specialist areas such as plant poisoning needs to be reconsidered.

    1. BBC News http://news.bbc.co.uk/1/hi/6658547.stm

    2. Dauncey E, Rayner TGJ (botany), Shah-Smith DA (mycology), Bates NS and others (toxicity monographs) (editors). 2000 Poisonous Plants in Britain and Ireland. CD-ROM.

    3. Poy JY, Racle JP, Benkhadra A, Colas A, Brenez M. [Aconitine intoxication. Cardiac arrhythmia successfully treated with mexiletine]. Cah Anesthesiol 1986 34(5):429-433.

    4. Winslow E. Evaluation of antagonism of aconitine-induced dysrhythmias in mice as a method of detecting and assessing antidysrhythmic activity. Br J Pharmacol 1980 71(2):615-22.

    http://emj.bmj.com/cgi/eletter-submit/25/4/217

    Read all letters published for this article

    Submit response
  25. Accurate ethical triage

    Arbon and colleagues [1] helpfully demonstrate the differences between major incident triage as taught on courses such as MIMMS [2], and that practised ¡§in the real world¡¨. I have two concerns however.

    Firstly, the authors incorrectly suggest that the role of ¡§scanning and sweeping¡¨ before undertaking triage has been de-emphasised in current teaching. In the MIMMS course, the mnemonic ¡§CSCATTT¡¨ places the ¡§A¡¨ of assessment ahead of ¡§T¡¨ for triage and this is firmly reinforced in both the manual and the course. An estimate of the number and type of casualties, hazards and so on, before triage, is emphasised strongly in current teaching.

    Secondly, the authors conclude that a complex process of paramedic decision making expanding beyond physiological parameters is preferable to ¡§theoretical models¡K such as triage sieve and sort¡¨. When time is available, triage can and does involve elements such as mechanism and anatomy of injury, and the experience of senior clinicians. This is described in MIMMS as secondary triage, and is concerned with subsequent patient disposition. However, triage sieve (and the American ¡§START¡¨) are both simple, rapid, repeatable, objective primary triage systems that are performed in the initial few minutes when immediate life-threats must be identified and prioritised without delay.

    Physiological primary trauma systems are based on the best evidence available, despite the difficulty establishing robust evidence in mass casualty incidents. Until there is evidence that other factors predict imminent mortality better than physiology, it would be dangerous to add subjective elements to the critical process of initial life-saving triage.

    Whether one approaches triage ethically from a utilitarian or an egalitarian position, the strongest imperative is simply to save the most lives.[3] To do this, triage should accurately predict which patients need the earliest life-saving intervention. But it should also minimise any subjective bias on the part of the practitioner, especially bias according to gender, race, age, disability, social usefulness or past merit. If practitioners move ¡§beyond¡¨ triage systems which focus solely on immediate life-threat, and instead apply ¡§gut-feeling¡¨ or subjective experience there is a danger that triage will be both inaccurate and unjust.

    It is important to appreciate the differences between what is taught and what is practised, and understand the reasons for those differences, but we must not assume that departure from what is taught is a sign of good or mature practice. Effort should be made instead to explain the ethical and clinical importance of accurate triage so that practitioners understand the need to follow standardised and simple protocols that save the most lives, and research must continue to improve our methods of primary triage.

    References

    1. Arbon P, Zeitz K, Ranse J et al. The reality of multiple casualty triage: putting triage theory into practice at the scene of multiple casualty vehicular accidents. Emerg Med J. 2008;25:230-4.

    2. Advanced Life Support Group (2002). Major incident medical management and support: the practical approach at the scene (2nd ed). London: BMJ, 2002.

    3. Winslow GR. Triage and justice. London: University of California Press, 1982.

    Read all letters published for this article

    Submit response

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EMJ.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.